Analysts/Institutional Investor Meet/Con. Call Updates

October 16, 2026 To, To, Listing Operation Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra Kurla Dalal Street, Mumbai – 400001 Complex, Bandra (East), Mumbai- 400051 (Scrip Code: 544644) (SYMBOL: CORONA) Dear Sir / Madam, Sub.: Intimation of Schedule of Analyst / Investor Call Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Company will hold its Q2 FY27 earnings conference call (i.e. post earnings / quarterly call) on Monday, November 02, 2026 at 11:30 a.m. (IST) to discuss the financial results of the Company for the second quarter and half year ended on September 30, 2026 as per details enclosed herewith. This intimation is also being made available on the website of the Company at www.coronaremedies.com You are requested to take note of the above. Thanking you. Your faithfully, For CORONA Remedies Limited Chetna Dharajiya Company Secretary and Compliance Officer Encl.: A/a 2QFY27 Earnings Call CORONA Remedies Limited November 02, 2026 at 11:30 am (IST) Ambit Capital cordially invites you to the Q2FY27 Earnings Call of CORONA Remedies Limited Company Representatives Mr. Nirav Mehta - Managing Director & CEO Mr. Ankur Mehta - Joint Managing Director Mr. Bhavin Bhagat - Chief Financial Officer The teleconference will be moderated by Umesh Laddha, Institutional Equities, Ambit Capital. Conference Call Details Date: November 02, 2026 | Time: 11:30 am (IST) Please join the conference via Diamond Pass to avoid wait time. Please click here to register. +91 22 6280 1148 Primary Access Numbers +91 22 7115 8049 Singapore: 800 101 2045 Hong Kong: 800 964 448 International Toll Free Numbers USA: 1 866 746 2133 UK: 0 808 101 1573 We request you to dial in a few minutes prior to the scheduled time.